This case underscores the diagnostic challenges posed by cryptic BCR-ABL1 rearrangements in CML, highlighting the importance of including upfront FISH analysis and using supplemental advanced molecular techniques for accurate diagnosis and appropriate therapeutic intervention. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.